Vol. 64, No. 1,1975
BIOCHEMICAL
AND BIOPHYSICAL
EFFECT OF N6, 2'-0-DIBUTYRYL THE INTERCONVERTIBLE
RESEARCH COMMUNICATIONS
CYCLIC AMP UPON
FORMS OF CYCLIC AMP
BHOSPHODIESTERASE FROM HUMAN PLATELETS Anne-Lise
Pichard
and Jean-Claude
Faculte de Medecine Cochin Port-Royal Institut de Pathologie Moleculaire Universite Paris V, 75014 Paris, France Received
March
21,1975
SUMMARY - The influence of dibutyryl cyclic AMP upon the equilibrium existing between three interconvertible forms - 2.5 S, 4.8 S and 7 S - of cyclic AMP phosphodiesterase from human platelets was investigated. It shifted the equilibrium towards the lighter form. It also exerted a protective effect against the thermo-inactivation of the enzyme. It is suggested that the analogue-induced equilibrium shift towards the dissociated high Km form of the phosphodiesterase might reflect a regulatory mechanism occuting also with natural cyclic nucleotides.
INTRODUCTION - Human
platelets
phosphodiesterase already that
activity,
been after
defined
to
1o-4
M)
and
species
depending
on
the
whose
"affinity"
specific
dissociated activity
observed It
equilibrium of
form,
was
the
which
a lower specific CAMP
is
lower.
forming
in In
an
(Km
this
latter
that
such
They
with
g
7 S correspond
enzyme
at
low
(3). enzyme
(Km
enzyme
: 3-5.
shown
association-disso-
CAMP
high
have
a 33,000
of
for At
we
S and
predominant
equilibrium
greater
4.8
concentration
"affinity"
is is
S, obtained.
(CAMP) have
(3), of
2.5
is
AMP
characteristics report
activity.
form for
its
were
molecular
a higher
of
3':5'-cyclic
sedimentation
activity
possesses
tion,
nism
- respectively
dissociated
concentration,
are
peaks
phosphodiesterase
the
some
a high
a previous
gradient
equilibrium
vitro
In
density
interconvertible
ciation In
three
CAMP
and
(1,2).
sucrose
supernatant, with
possess
: 3-5.
concentra-
associated 10m5M)
condition
forms
and both
whose Km's
(3). tempting also
regulation.
to takes
assume place
Any
Cop.vrigh t o 19 75 by Academic Press. Im. AN rights of reproduction in ary form reserved.
1 igand
in
vivo modify
342
a transconformational
and might ing the
represent equilibrium
a mechawould
BIOCHEhdd
Vol. 64, No. 1,1975
induce
modifications
other
hand
sion,
or
fully
associated
single
it
of
would
even
to
be
AMP
as well
as
of
outdated
platelet
National
de
and
ending
with
As
previously
vol.
of
S04,
and
dies.
in
enzyme
(3),
CAMP which
is
to
the
added
the
curve
600 ce
ug of
When
some
shifted
protein
per
This sedimentation. (3),
three
values peaks
the was
compatible
with
in
sucrose in
of
the
sucrose
3
stu-
by
level was
of
due by
the
of
me-
2mM
carried
out
pg
wt
against previously
a concentration
dibutyryl
CAMP,
(5),
concentration
protein
per
dibutyryl
of
is
an lmM,
prolonged ml
in
CAMP
to
the
absen
prevents
to
enzyme. by
sucrose (fig.
2),
density gradient as already reported
were
ratios
of
1 :
obtained,
When
density
gradient, shifted
343
with
2 : 4 . Any
reconcentration (3).
was
as
plateau
phosphodiesterase after
plotted
phosphodiesterase
the
that
the
to
a final
260
suggests
was
If
and
gradient
phosphodiesterase
in
2 mM Mg
we obtained, is
at
right,
mol.
-20°C.
subsequent
measured
activity
which
of
others
at
prepared
all
gradient
assay,
demonstrated conditions
the
steps,
containing was
degraded
instead
CAMP
(Centre erythrocy-
stored
a saturating
In standard of
several
donors
were for
(fig.1).
not
This
further
generated
incorporated
at
enzyme
the
aggregation
peaks
dimentation pattern
ml
CAMP,
fig.2.
the
the
of
combining
was
used
density
extract to
analogue.
extent
is
one
2'-0-dibutyryl
N6,
blood
pH 7.4, was
curve
platelet
is
the
which
equilibrium
of
with
centrifugation
extracts
(4)
in
analogue
only
Contaminating
platelets
to
a triphasic
from
activity
legend
aggregation
by
sequential
buffer,
concentration
the
analogue
platelet
sucrose
RESULTS AND DISCUSSIONreported
by
Appleman
the
deal of
Paris).
g supernatant
in
to
prepared
CAMP phosphodiesterase
as described
dependent
of (2),
and
interconver-
towards
strength.
units
removed
pellet
33,000
thod of Thompson CAMP. Sedimentation
the
ionic
were
50 mM Tris-Hcl
the
The
and
plasma
described
as
the
metabolised
Sanguine, were
a pure
cold
heat
enriched
leukocytes
block
influence
a non
platelets
Transfusion
so
the
the
Human
equilibrium
On the
studies.
CAMP),
-
to
the form
subsequent
kinetics.
useful
shift
(dibutyryl
EXPERIMENTAL
tes
extremely
investigated effect
RESEARCH COMMUNKATIONS
phosphodiesterase
dissociated
for
We therefore cyclic
the
completely or
species
AND BIOPHYSICAL
of
followed
by
1 mM dibutyryl the towards
S
these rese-
CAMP was
distribution the
lighter
peak
BIOCHEMICAL
Vol. 64, No. 1,1975
AND BIOPHYSICAL
untreated
200
400
RESEARCH COMMUNICATIONS
extract
1200
800
1600
pg Fig.
1
proteins/ ml
Influence of dibutyryl CAMP upon the enzyme concentration dance of CAMP phosphodiesterase activity (assayed with CAMP, in a final volume of 0.5 ml). -
: no dibutyryl
o-O-0
: 1 n$l dibutyryl
depen2 m M
CAMP added CAMP in the
extract
and in the
assay.
The inhibitory effect of dibutyryl CAMP was more pronounced at high enzyme concentration (50 %) than at low enzyme concentration (25 X)
(fig.
2).
tyryl ring
This
finding
CAMP did
confirms
influence
the
dissociated
The
dibutyryl
no min,
was loss
of of
be more
at in
absence
of
had
a protective
(fig.
favo-
of
suggests
for there
This the
finding, this
the
a platelet
exCAMP,
the
first
was
a 50
combined
equilibrium
that
on
1 mM dibutyryl
analogue 3).
shift
2),
of occurred
the
effect
When
presence
activity
induced
(fig.
by
dibu-
towards latter
form
20 % with the might
thermostable.
CONCLUSION
- The
ce
this
because
the
that
equilibrium
phosphodiesterase. in
activity
CAMP form
conclusion
enzyme.
also
the
51'C
the
enzyme
dibutyryl
dissociated
the
phosphodiesterase
although
decrease the
of
heated
foregoing
interconversion
of
derivative
thermo-inactivation tract
the form
our
effects
of
dibutyryl
compound
had
been
344
found
CAMP
are
to
be
of
great
significan-
a non-competitive
BIOCHEMICAL
vol. 64, No. 1,1975
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
NO dibutyrYlec/AMP
o.+
18 Dibutyryl-cAMP
10-i
I
I 5
Fig.
2
II Fractions
18
Effect of dibutyryl CAMP upon the sedimentation pattern of platelet CAMP phosphodiesterase in a sucrose density gradient. 0.2 ml of platelet extract containing 1 mg protein was layered onto 5 ml tubes containing a linear (5 to 20 %) sucrose density gradient made in the extraction medium. After centrifugation at 38,000 rpm in a Spinco S W 39 rotor, the bottom of the tubes was punctured, and 0.2 ml fractions were collected and assayed for cAyP phosphodiesterase (4) with 2 mM unlabelled CAMP and 20 nM (8 - H) CAMP (ca. 200,000 cpm in 0.5 ml). S values were calculated according to the method of Martin and Ames (6). When present,dibutyryl CAMP was 1 mmolar in the sucrose gradient.
Heating
:
ot 51° C
Without
dibutyryl.cAMP
15
50
2_
\ 4 x -1 103, 1
45
60
Minutes
Fig.
3
Effect of heating 12 mg prot/ml. e
:
l
O-04 No dibutyryl
at 51" C a platelet
: in the absence : in the presence cAMP was added
345
extract
of dibutyryl
CAMP
of 1 mM dibutyryl in the
test
containing
tube
CAMP during
the
assay.
BIOCHEMICAL
Vol. 64, No. 1,1975
inhibitor and
of
to
be
phosphodiesterase
unpublished tic
data). and
at This
substrate
substrate
suggests
possibly
concentration,
concentration
the
regulatory
We demonstrate induces
leading
the
That
enzyme this
cular
here
drastic
equilibrium
of
low
high
existence site
(personal
on
distinct
the
enzyme
from
the
of
cataly-
site.
logue of
at
uncompetitive
a binding,
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
S)
analogue the
gands,
such
predominance
of
with
lower equilibrium
by
for
the
substrate.
its
represents
the
mole-
kinetics
possibility.
effecters,
anaform
cooperativity"
a likely
modifying
substrate
a dissociated
shift
"negative is
this
transconformational
"affinity"
pharmacological
effect
convertible
the
(7)
as
regulatory
of
enzyme
apparent
phosphodiesterase
binding the
induced
for
the in
to
(2.5
basis
that
changes
Artificial
might
also
equilibrium
li-
exert
between
a
the
inter-
forms. ACKNOWLEDGMENTS
We thank stimulating Recherche
Prof.
K. Goldberg
discussions. Scientifique
This
J. Hanoune for
and Dr. work
was supported
Institut
and the
much fruitful
by the Centre
National
de la Sante
and
National
de la
et de la Recherche
Medicale. REFERENCES
1.
Song, S.Y. 593 (1971).
2.
Pichard, Acta,
315,
and
Cheung,
W.Y.,
A.L., 370
Hanoune, (1973).
J.
A.L., (1975).
and
Kaplan
3.
Pichard, 280, 673,
4.
Thompson, (1971).
5.
Miller, J.P., Stewart, C.M., Biochemistry,
6.
Martin,
7.
Russell, T.R., Thompson, M.M., Proc. Nat. Acad.
N.J.
R.G.
Biochim. and
Kaplan,
J.C.,
C.R.
and Appleman,
M.M.,
Ames,
J.
B.N.,
W.J., Sci,
U.S.
346
J.C.,
Acta,
Biol.
242,
Biochim.
Acad.
Sci.,
Biochemistry,
Shuman, D.A., Scholten, Khwaja, T.A., Robins, 12, 1010 (1973). and
Biophys.
Biophys.
Paris, 10,
311,
M.B., Dimmitt, M.K., R.K. and Simon,L.N., Chem.,
Schneider, 69, 1791
236, F.W. and (1972).
1372
(1961).
Appleman,